Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Rx Cost-Containment Task Force Headed By Deputy Secretary Allen

Executive Summary

HHS Deputy Secretary Claude Allen is heading a task force to examine prescription drug costs

You may also be interested in...



HHS policy on Rx costs

HHS says it does not have a formal task force looking at prescription drug costs, but does consider the issue regularly. FDA Deputy Commissioner Lester Crawford, PhD, said during a House Ag Appropriations hearing that an HHS task force was examining Rx cost containment issues (11"The Pink Sheet" March 25, p. 10)...

HHS policy on Rx costs

HHS says it does not have a formal task force looking at prescription drug costs, but does consider the issue regularly. FDA Deputy Commissioner Lester Crawford, PhD, said during a House Ag Appropriations hearing that an HHS task force was examining Rx cost containment issues (11"The Pink Sheet" March 25, p. 10)...

Rx Reimportation Bill In Senate Will Focus On Canada, Sen. Dorgan Says

Prescription drug reimportation advocates in the Senate are focusing on a Canada-only approach for 2001.

UsernamePublicRestriction

Register

PS039543

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel